Filing Details

Accession Number:
0000899243-21-042705
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-03 16:16:56
Reporting Period:
2021-11-02
Accepted Time:
2021-11-03 16:16:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1656536 Decibel Therapeutics Inc. DBTX Pharmaceutical Preparations (2834) 464198709
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1842132 Anna Trask C/O Decibel Therapeutics, Inc.
1325 Boylston Street, Suite 500
Boston MA 02215
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-11-02 4,913 $8.31 7,911 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.11 to $8.395, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.